18 December 2000 Promising cancer treatment modality: the University of California Davis/McClellan Nuclear Radiation Center neutron capture therapy program
Author Affiliations +
Abstract
Neutron capture therapy (NCT) is a promising new binary therapeutic modality for the treatment of localized tumors. It is accomplished by injection and localization within the tumor of a neutron capture agent (NCA) that alone, is non- toxic. Whenthe tumor is then exposed to neutrons, a relatively non-toxic form of radiation, crytotoxic products are produced that directly or indirectly cause tumor cell death, and yet preserves normal surrounding tissue not contain the NCA. The UC Davis NCT program is currently working to develop and test new compounds or NCA in vitro and in vivo. Many groups worldwide are also working to develop the next generation NCA, but less than five facilities internationally are currently capable to treating clinical brain tumor patients by NCT and only two US facilities, MIT and Brookhaven National Laboratory. In addition to compound development, the UC Davis NCT program is preparing the UC Davis McClellan Nuclear Radiation Center's 2 megawatt TRIGA reactor for NCT clinical trials which would make it the only such facility on the West Coast.
© (2000) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Susan A. Autry-Conwell, Susan A. Autry-Conwell, James E. Boggan, James E. Boggan, Benjamin F. Edwards, Benjamin F. Edwards, Yongjin Hou, Yongjin Hou, Maria-Graca Vincente, Maria-Graca Vincente, Hungyuan Liu, Hungyuan Liu, Wade J. Richards, Wade J. Richards, } "Promising cancer treatment modality: the University of California Davis/McClellan Nuclear Radiation Center neutron capture therapy program", Proc. SPIE 4142, Penetrating Radiation Systems and Applications II, (18 December 2000); doi: 10.1117/12.410584; https://doi.org/10.1117/12.410584
PROCEEDINGS
4 PAGES


SHARE
Back to Top